Medpace Holdings, Inc. (MEDP) Earnings Yield: 3.45%
Is Medpace Holdings, Inc.’s earnings yield high or low?
Medpace Holdings, Inc.'s earnings yield of 3.45% is 10% above its 5-year average of 3.13%, around the middle of its 5-year range (2.12%–4.64%).
As of Wednesday, June 17, 2026. 13.08% above its 12-month average of 3.05%.
MEDP Earnings Yield Chart
MEDP Average Earnings Yield Chart
MEDP Current vs Average Earnings Yield Chart
MEDP Earnings Yield Metrics
EARNINGS YIELD
3.45%
EARNINGS YIELD AVG TTM
3.05%
EARNINGS YIELD AVG 3Y
3.12%
EARNINGS YIELD AVG 5Y
3.13%
EARNINGS YIELD AVG 10Y
2.88%
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
+13.08%
CURRENT VS 3Y AVG
+10.62%
CURRENT VS 5Y AVG
+10.20%
CURRENT VS 10Y AVG
+19.93%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MEDP Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $13.18B | 3.45% | 3.05% | 3.12% | 3.13% |
| The Cooper Companies, Inc. (COO)vs › | $13.14B | 1.75% | 2.74% | 2.25% | 12.65% |
| Solventum Corporation (SOLV)vs › | $13.26B | 10.67% | 8.18% | 8.17% | 8.17% |
| DaVita Inc. (DVA)vs › | $13.46B | 4.76% | 7.11% | 6.45% | 6.99% |
| Align Technology, Inc. (ALGN)vs › | $12.86B | 3.32% | 3.52% | 2.68% | 2.48% |
| Revvity, Inc. (RVTY)vs › | $11.29B | 2.07% | 2.32% | 3.16% | 3.75% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | N/A | 3.00% | 10.30% | 8.48% |
| Baxter International Inc. (BAX)vs › | $10.19B | N/A | 10.19% | 8.29% | 5.38% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 3.16% | 3.63% | 3.48% | 5.61% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.90B | N/A | 3.32% | 3.92% | 3.29% |
Earnings Yield vs P/E Ratio
Earnings Yield
3.45%
EPS ÷ Price
P/E Ratio
29.0
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
Medpace Holdings, Inc. Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medpace Holdings, Inc. Earnings Yield FAQ
- What is the earnings yield for Medpace Holdings, Inc. (MEDP)?
- The earnings yield for MEDP stock is 3.45%.
- Is Medpace Holdings, Inc.'s earnings yield high or low?
- Medpace Holdings, Inc.'s earnings yield of 3.45% is 10% above its 5-year average of 3.13%, around the middle of its 5-year range (2.12%–4.64%).
- What is the TTM average earnings yield for Medpace Holdings, Inc. (MEDP)?
- The TTM average earnings yield for MEDP stock is 3.05%.
- What is the 3Y average earnings yield for Medpace Holdings, Inc. (MEDP)?
- The 3Y average earnings yield for MEDP stock is 3.12%.
- What is the 5Y average earnings yield for Medpace Holdings, Inc. (MEDP)?
- The 5Y average earnings yield for MEDP stock is 3.13%.
- What is the 10Y average earnings yield for Medpace Holdings, Inc. (MEDP)?
- The 10Y average earnings yield for MEDP stock is 2.88%.
Medpace Holdings, Inc. Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-16 | 3.45% |
| 2026-06-15 | 3.40% |
| 2026-06-12 | 3.41% |
| 2026-06-11 | 3.35% |
| 2026-06-10 | 3.42% |
| 2026-06-09 | 3.41% |
| 2026-06-08 | 3.48% |
| 2026-06-05 | 3.51% |
| 2026-06-04 | 3.47% |
| 2026-06-03 | 3.53% |
| 2026-06-02 | 3.57% |
| 2026-06-01 | 3.53% |
| 2026-05-29 | 3.56% |
| 2026-05-28 | 3.55% |
| 2026-05-27 | 3.72% |
| 2026-05-26 | 3.71% |
| 2026-05-22 | 3.68% |
| 2026-05-21 | 3.70% |
| 2026-05-20 | 3.77% |
| 2026-05-19 | 3.79% |
| 2026-05-18 | 3.79% |
| 2026-05-15 | 3.83% |
| 2026-05-14 | 3.80% |
| 2026-05-13 | 3.76% |
| 2026-05-12 | 3.79% |
| 2026-05-11 | 3.82% |
| 2026-05-08 | 3.76% |
| 2026-05-07 | 3.71% |
| 2026-05-06 | 3.73% |
| 2026-05-05 | 3.70% |
| 2026-05-04 | 3.82% |
| 2026-05-01 | 3.81% |
| 2026-04-30 | 3.80% |
| 2026-04-29 | 3.85% |
| 2026-04-28 | 3.89% |
| 2026-04-27 | 3.78% |
| 2026-04-24 | 3.88% |
| 2026-04-23 | 4.05% |
| 2026-04-22 | 3.01% |
| 2026-04-21 | 2.97% |
| 2026-04-20 | 2.90% |
| 2026-04-17 | 2.94% |
| 2026-04-16 | 2.97% |
| 2026-04-15 | 2.95% |
| 2026-04-14 | 2.94% |
| 2026-04-13 | 3.05% |
| 2026-04-10 | 3.10% |
| 2026-04-09 | 3.05% |
| 2026-04-08 | 2.94% |
| 2026-04-07 | 3.01% |
| 2026-04-06 | 3.09% |
| 2026-04-02 | 3.07% |
| 2026-04-01 | 3.13% |
| 2026-03-31 | 3.19% |
| 2026-03-30 | 3.33% |
| 2026-03-27 | 3.39% |
| 2026-03-26 | 3.28% |
| 2026-03-25 | 3.28% |
| 2026-03-24 | 3.32% |
| 2026-03-23 | 3.35% |
| 2026-03-20 | 3.38% |
| 2026-03-19 | 3.32% |
| 2026-03-18 | 3.37% |
| 2026-03-17 | 3.36% |
| 2026-03-16 | 3.37% |
| 2026-03-13 | 3.40% |
| 2026-03-12 | 3.45% |
| 2026-03-11 | 3.21% |
| 2026-03-10 | 3.28% |
| 2026-03-09 | 3.20% |
| 2026-03-06 | 3.25% |
| 2026-03-05 | 3.26% |
| 2026-03-04 | 3.29% |
| 2026-03-03 | 3.29% |
| 2026-03-02 | 3.35% |
| 2026-02-27 | 3.39% |
| 2026-02-26 | 3.42% |
| 2026-02-25 | 3.50% |
| 2026-02-24 | 3.46% |
| 2026-02-23 | 3.44% |
| 2026-02-20 | 3.37% |
| 2026-02-19 | 3.43% |
| 2026-02-18 | 3.43% |
| 2026-02-17 | 3.58% |
| 2026-02-13 | 3.58% |
| 2026-02-12 | 3.68% |
| 2026-02-11 | 3.61% |
| 2026-02-10 | 3.43% |
| 2026-02-09 | 2.70% |
| 2026-02-06 | 2.64% |
| 2026-02-05 | 2.64% |
| 2026-02-04 | 2.55% |
| 2026-02-03 | 2.52% |
| 2026-02-02 | 2.43% |
| 2026-01-30 | 2.46% |
| 2026-01-29 | 2.41% |
| 2026-01-28 | 2.39% |
| 2026-01-27 | 2.38% |
| 2026-01-26 | 2.38% |
| 2026-01-23 | 2.43% |
| 2026-01-22 | 2.36% |
| 2026-01-21 | 2.31% |
| 2026-01-20 | 2.38% |
| 2026-01-16 | 2.34% |
| 2026-01-15 | 2.32% |
| 2026-01-14 | 2.32% |
| 2026-01-13 | 2.35% |
| 2026-01-12 | 2.39% |
| 2026-01-09 | 2.41% |
| 2026-01-08 | 2.38% |
| 2026-01-07 | 2.33% |
| 2026-01-06 | 2.35% |
| 2026-01-05 | 2.44% |
| 2026-01-02 | 2.51% |
| 2025-12-31 | 2.55% |
| 2025-12-30 | 2.52% |
| 2025-12-29 | 2.51% |
| 2025-12-26 | 2.52% |
| 2025-12-24 | 2.50% |
| 2025-12-23 | 2.51% |
| 2025-12-22 | 2.50% |
| 2025-12-19 | 2.52% |
| 2025-12-18 | 2.55% |
| 2025-12-17 | 2.57% |
| 2025-12-16 | 2.56% |
| 2025-12-15 | 2.56% |
| 2025-12-12 | 2.56% |
| 2025-12-11 | 2.53% |
| 2025-12-10 | 2.55% |
| 2025-12-09 | 2.63% |
| 2025-12-08 | 2.61% |
| 2025-12-05 | 2.61% |
| 2025-12-04 | 2.63% |
| 2025-12-03 | 2.48% |
| 2025-12-02 | 2.45% |
| 2025-12-01 | 2.43% |
| 2025-11-28 | 2.42% |
| 2025-11-26 | 2.36% |
| 2025-11-25 | 2.34% |
| 2025-11-24 | 2.31% |
| 2025-11-21 | 2.42% |
| 2025-11-20 | 2.44% |
| 2025-11-19 | 2.42% |
| 2025-11-18 | 2.42% |
| 2025-11-17 | 2.44% |
| 2025-11-14 | 2.42% |
| 2025-11-13 | 2.42% |
| 2025-11-12 | 2.39% |
| 2025-11-11 | 2.37% |
| 2025-11-10 | 2.38% |
| 2025-11-07 | 2.43% |
| 2025-11-06 | 2.42% |
| 2025-11-05 | 2.39% |
| 2025-11-04 | 2.41% |
| 2025-11-03 | 2.41% |
| 2025-10-31 | 2.45% |
| 2025-10-30 | 2.47% |
| 2025-10-29 | 2.45% |
| 2025-10-28 | 2.46% |
| 2025-10-27 | 2.40% |
| 2025-10-24 | 2.36% |
| 2025-10-23 | 2.40% |
| 2025-10-22 | 2.46% |
| 2025-10-21 | 2.46% |
| 2025-10-20 | 2.47% |
| 2025-10-17 | 2.55% |
| 2025-10-16 | 2.58% |
| 2025-10-15 | 2.62% |
| 2025-10-14 | 2.60% |
| 2025-10-13 | 2.55% |
| 2025-10-10 | 2.68% |
| 2025-10-09 | 2.59% |
| 2025-10-08 | 2.53% |
| 2025-10-07 | 2.53% |
| 2025-10-06 | 2.54% |
| 2025-10-03 | 2.53% |
| 2025-10-02 | 2.51% |
| 2025-10-01 | 2.47% |
| 2025-09-30 | 2.62% |
| 2025-09-29 | 2.69% |
| 2025-09-26 | 2.71% |
| 2025-09-25 | 2.76% |
| 2025-09-24 | 2.70% |
| 2025-09-23 | 2.71% |
| 2025-09-22 | 2.70% |
| 2025-09-19 | 2.70% |
| 2025-09-18 | 2.68% |
| 2025-09-17 | 2.70% |
| 2025-09-16 | 2.74% |
| 2025-09-15 | 2.71% |
| 2025-09-12 | 2.74% |
| 2025-09-11 | 2.70% |
| 2025-09-10 | 2.82% |
| 2025-09-09 | 2.77% |
| 2025-09-08 | 2.73% |
| 2025-09-05 | 2.76% |
| 2025-09-04 | 2.79% |
| 2025-09-03 | 2.79% |
| 2025-09-02 | 2.84% |
| 2025-08-29 | 2.83% |
| 2025-08-28 | 2.84% |
| 2025-08-27 | 2.84% |
| 2025-08-26 | 2.87% |
| 2025-08-25 | 2.88% |
| 2025-08-22 | 2.90% |
| 2025-08-21 | 2.97% |
| 2025-08-20 | 2.89% |
| 2025-08-19 | 2.91% |
| 2025-08-18 | 2.91% |
| 2025-08-15 | 2.94% |
| 2025-08-14 | 2.93% |
| 2025-08-13 | 2.87% |
| 2025-08-12 | 2.93% |
| 2025-08-11 | 2.99% |
| 2025-08-08 | 3.10% |
| 2025-08-07 | 3.14% |
| 2025-08-06 | 3.13% |
| 2025-08-05 | 3.08% |
| 2025-08-04 | 3.11% |
| 2025-08-01 | 3.18% |
| 2025-07-31 | 3.15% |
| 2025-07-30 | 3.07% |
| 2025-07-29 | 3.00% |
| 2025-07-28 | 2.97% |
| 2025-07-25 | 3.01% |
| 2025-07-24 | 2.95% |
| 2025-07-23 | 3.08% |
| 2025-07-22 | 2.82% |
| 2025-07-21 | 4.24% |
| 2025-07-18 | 4.20% |
| 2025-07-17 | 4.11% |
| 2025-07-16 | 4.16% |
| 2025-07-15 | 4.19% |
| 2025-07-14 | 4.09% |
| 2025-07-11 | 4.05% |
| 2025-07-10 | 3.99% |
| 2025-07-09 | 4.08% |
| 2025-07-08 | 4.06% |
| 2025-07-07 | 4.11% |
| 2025-07-03 | 4.07% |
| 2025-07-02 | 4.02% |
| 2025-07-01 | 4.08% |
| 2025-06-30 | 4.17% |
| 2025-06-27 | 4.22% |
| 2025-06-26 | 4.27% |
| 2025-06-25 | 4.21% |
| 2025-06-24 | 4.15% |
| 2025-06-23 | 4.24% |
| 2025-06-20 | 4.23% |
| 2025-06-18 | 4.33% |
| 2025-06-17 | 4.40% |
| 2025-06-16 | 4.35% |
| 2025-06-13 | 4.39% |
| 2025-06-12 | 4.31% |
| 2025-06-11 | 4.33% |
| 2025-06-10 | 4.28% |
| 2025-06-09 | 4.39% |
| 2025-06-06 | 4.42% |
| 2025-06-05 | 4.46% |
| 2025-06-04 | 4.19% |
Showing the most recent 260 of 2,416 data points. The chart above shows the full history.
Related Metrics
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle